Enovix Co. (NASDAQ:ENVX – Get Free Report) shares traded up 5.1% during trading on Friday . The company traded as high as $12.93 and last traded at $12.72. 1,741,676 shares were traded during mid-day trading, a decline of 78% from the average session volume of 7,887,829 shares. The stock had previously closed at $12.11.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on ENVX. Benchmark reiterated a “buy” rating and set a $25.00 target price on shares of Enovix in a research note on Wednesday, October 30th. JPMorgan Chase & Co. lowered their price target on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a report on Wednesday, October 30th. Finally, Janney Montgomery Scott cut shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 target price on the stock. in a report on Thursday, October 31st. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Enovix presently has an average rating of “Moderate Buy” and an average price target of $20.50.
View Our Latest Report on ENVX
Enovix Stock Up 6.4 %
Enovix (NASDAQ:ENVX – Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.03. The firm had revenue of $4.30 million for the quarter, compared to analyst estimates of $4.11 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. During the same period in the previous year, the firm earned ($0.27) earnings per share. On average, research analysts predict that Enovix Co. will post -1.17 EPS for the current fiscal year.
Insider Activity at Enovix
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the sale, the director now directly owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. The trade was a 42.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 15.70% of the stock is currently owned by corporate insiders.
Institutional Trading of Enovix
A number of institutional investors and hedge funds have recently modified their holdings of ENVX. Driehaus Capital Management LLC grew its position in shares of Enovix by 63.7% in the second quarter. Driehaus Capital Management LLC now owns 3,886,492 shares of the company’s stock valued at $60,085,000 after purchasing an additional 1,512,424 shares in the last quarter. Geode Capital Management LLC raised its holdings in Enovix by 5.4% during the 3rd quarter. Geode Capital Management LLC now owns 3,583,685 shares of the company’s stock valued at $33,477,000 after buying an additional 182,757 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Enovix by 6.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,229,052 shares of the company’s stock valued at $11,479,000 after buying an additional 73,320 shares during the period. Stifel Financial Corp grew its stake in Enovix by 6.2% in the third quarter. Stifel Financial Corp now owns 950,202 shares of the company’s stock worth $8,875,000 after purchasing an additional 55,094 shares during the period. Finally, Old West Investment Management LLC increased its stake in shares of Enovix by 12.3% in the 3rd quarter. Old West Investment Management LLC now owns 937,838 shares of the company’s stock worth $8,759,000 after acquiring an additional 102,452 shares in the last quarter. 50.92% of the stock is owned by hedge funds and other institutional investors.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories
- Five stocks we like better than Enovix
- Using the MarketBeat Stock Split Calculator
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Health Care Stocks Explained: Why You Might Want to Invest
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.